About Company

    Validating a Century-Old
    Scientific Vision Today
    The Journey of
    Microbiome Research
    and Development
    The Journey of
    Microbiome Research
    and Development
    The Journey of
    Microbiome
    Research
    and Development
    Elie Metchnikoff (1845–1916), a microbiologist and founder of immunology, was awarded the Nobel Prize in Physiology or Medicine for his pioneering research on phagocytosis, a fundamental concept of innate immunity. Another of his major contributions was his research into the relationship between intestinal microorganisms and human health.
    Metchnikoff proposed that aging is influenced by toxic bacteria in the gut and theorized that consuming fermented milk rich in beneficial bacteria could help extend human lifespan. His hypothesis began to gain scientific validation in the mid-2000s, when research into the human microbiome revealed its significant role in maintaining health and influencing disease development.
    The human microbiota exists throughout the body across a lifetime and plays a profound role in human physiology. Beyond identifying microbial populations, modern research has expanded to explore how microorganisms contribute to disease progression, the mechanisms through which they support disease treatment, and their role in restoring human health.
    Microorganisms, which outnumber human cells (approximately 30 trillion), interact dynamically with the human body and perform essential biological functions. ATOGEN conducts research into these complex interactions and develops microbiome-based therapeutics designed to restore microbial balance and treat disease. Through continuous research and innovation, ATOGEN strives to realize the vision of life extension first envisioned by Metchnikoff over a century ago.

    Management Philosophy

    A New Global Leader, ATOGEN

    VisionTo become a global leader
    in microbiome therapeutics

    MissionTo realize life extension
    through the development of
    microbiome-based therapeutics

    Core ValuesExpertise, Responsibility,
    Harmony, Respect

    Pharmaceutical

    We develop innovative therapeutics based on deep expertise in microbiome-based drug development, differentiated pipelines, and rigorous scientific evidence

    Nutraceutical

    We possess industry-leading development capabilities, encompassing the discovery, development, regulatory approval, and successful commercialization of probiotic-based healthcare ingredients

    Cosmeceutical

    We maintain extensive expertise and product development experience in cosmeceutical applications.